Skip to main content
. Author manuscript; available in PMC: 2012 Nov 7.
Published in final edited form as: Int J Cancer. 2011 Feb 15;128(4):944–950. doi: 10.1002/ijc.25413

Table 2.

Age-Adjusted Associations of Reproductive Factors and Hormone Use With Risk of Glioma Among 225,355 Women in the NIH-AARP Diet and Health Study

Gliomas (N = 174) Person-years HRa (95% CI)
Age at menarche (yrs)
 <13 77 790,914 1.00 (reference)
 13–14 70 669,902 1.06 (0.74, 1.46)
 ≥15 23 151,592 1.53 (0.96, 2.44)
 Missing 4 17,108
P for trend 0.16
Age at first live birth (yrs)
 Nulliparous 28 235,516 1.00 (reference)
 <20 32 284,450 0.95 (0.57, 1.58)
 20–24 68 699,601 0.79 (0.51, 1.23)
 ≥30 41 383,175 0.87 (0.54, 1.40)
 Missing 5 26,775
Parous/nulliparous
 Nulliparous 30 248,161 1.00 (reference)
 Parous 140 1,363,196 0.83 (0.56, 1.23)
 Missing 4 18,159
Parity
 Nulliparous 30 248,161 1.00 (reference)
 1 19 169,685 0.93 (0.52, 1.65)
 2 41 422,117 0.80 (0.50, 1.28)
 ≥3 80 771,394 0.83 (0.54, 1.26)
 Missing 4 2,548
History of hysterectomy
 No 81 919,284 1.00 (reference)
 Yes 87 687,972 1.42 (1.05, 1.92)
 Missing 6 22,259
History of oophorectomy
 No 109 1,117,365 1.00 (reference)
 Both ovaries removed 48 376,483 1.01 (0.58, 1.76)
 Other surgery 12 103,557 0.78 (0.47, 1.31)
 Missing 5 32,112
Menopausal status
 Premenopausal 7 70,842 1.14 (0.52, 2.49)
 Postmenopausal 164 1,537,075 1.00 (reference)
 Missing 3 21,600
Type of menopauseb
 Natural 87 880,004 1.00 (reference)
 Surgery/radiation/chemo 77 643,657 1.23 (0.90, 1.67)
 Missing 6 66,956
Age at menopauseb
 ≥50 56 608,858 1.00 (reference)
 45–49 43 386,466 1.17 (0.80, 1.72)
 <45 65 541,751 1.27 (0.91–1.79)
 Missing 3 21,500
Oral contraceptive use
 Never 117 970,560 1.00 (reference)
 Ever 53 633,935 0.74 (0.53, 1.05)
 Missing 4 25,021
Duration of OC use
 Never 117 970,560 1.00 (reference)
 1–4 yrs 23 282,728 0.73 (0.46, 1.15)
 5–9 yrs 17 198,153 0.77 (0.45, 1.29)
 ≥10 yrs 13 153,054 0.75 (0.42, 1.34)
 Missing 4 25,021
P for trend 0.22
Hormone therapy
 Never 87 770,682 1.00 (reference)
 Ever 87 858,834 0.94 (0.72, 1.23)
Hormone therapy
 Never 87 770,682 1.00 (reference)
 Former 17 161,149 1.16 (0.75, 1.78)
 Current 70 695,008 1.05 (0.94, 1.18)
Duration of hormone use
 Never 80 728,152 1.00 (reference)
 <5 yrs 33 312,649 1.17 (0.82, 1.67)
 5–9 yrs 22 214,010 0.91 (0.58, 1.41)
 ≥10 yrs 32 329,564 0.83 (0.57, 1.20)
 Missing 7 6,318
P for trend 0.23

Abbreviations: HR, hazard ratio; CI, confidence interval.

a

Adjusted for age at entry as a continuous variable.

b

Restricted to postmenopausal women.

Missing values: age at menarche (4 cases/2397 non-cases); age at first live birth (5 cases/3738 non-cases); parity (4 cases/2544 non-cases); hysterectomy status (6 cases/3120 non-cases); oophorectomy status (5 cases/4494 non-cases); menopausal status (3/3012), age at menopause (3 cases/3012 non-cases); oral contraceptive use (4 cases/3499 non-cases); duration of oral contraceptive use (4 cases/3499 non-cases); ever hormone use (0 cases/0 non-cases); hormone status (0 cases/374 non-cases); years of hormone therapy (7 cases/6311 non-cases).